Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1945288
Max Phase: Preclinical
Molecular Formula: C36H61N3O7Si
Molecular Weight: 675.98
Molecule Type: Small molecule
Associated Items:
ID: ALA1945288
Max Phase: Preclinical
Molecular Formula: C36H61N3O7Si
Molecular Weight: 675.98
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCCC(=O)N[C@@H](CCCCNC(=O)OCc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(CO[Si](C)(C)C(C)(C)C)CO1
Standard InChI: InChI=1S/C36H61N3O7Si/c1-9-10-11-15-21-31(40)38-29(20-16-17-22-37-34(43)44-24-28-18-13-12-14-19-28)33(42)39-30(23-27(2)3)32(41)36(25-45-36)26-46-47(7,8)35(4,5)6/h12-14,18-19,27,29-30H,9-11,15-17,20-26H2,1-8H3,(H,37,43)(H,38,40)(H,39,42)/t29-,30-,36-/m0/s1
Standard InChI Key: NQQSROMDMOOYIC-ABCZBHHISA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 675.98 | Molecular Weight (Monoisotopic): 675.4279 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Carmony KC, Lee DM, Wu Y, Lee NR, Wehenkel M, Lee J, Lei B, Zhan CG, Kim KB.. (2012) A bright approach to the immunoproteasome: development of LMP2/β1i-specific imaging probes., 20 (2): [PMID:21741845] [10.1016/j.bmc.2011.06.039] |
Source(1):